GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allied Biotech Corp (ROCO:1780) » Definitions » Additional Paid-In Capital

Allied Biotech (ROCO:1780) Additional Paid-In Capital : NT$8.2 Mil(As of Jun. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Allied Biotech Additional Paid-In Capital?


Allied Biotech's quarterly additional paid-in capital increased from Jun. 2023 (NT$6.0 Mil) to Dec. 2023 (NT$7.7 Mil) and increased from Dec. 2023 (NT$7.7 Mil) to Jun. 2024 (NT$8.2 Mil).

Allied Biotech's annual additional paid-in capital increased from Dec. 2021 (NT$5.2 Mil) to Dec. 2022 (NT$5.7 Mil) and increased from Dec. 2022 (NT$5.7 Mil) to Dec. 2023 (NT$7.7 Mil).


Allied Biotech Additional Paid-In Capital Historical Data

The historical data trend for Allied Biotech's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allied Biotech Additional Paid-In Capital Chart

Allied Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.26 3.89 5.19 5.67 7.74

Allied Biotech Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.50 5.67 5.98 7.74 8.22

Allied Biotech Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Allied Biotech Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Allied Biotech's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Allied Biotech Business Description

Traded in Other Exchanges
N/A
Address
No. 76 Tun Hua S. Road, Sec. 2, 12th Floor, Taipei, TWN
Allied Biotech Corp is a Taiwan based manufacturer of carotenoids. It manufactures carotenoid formulations for the food, supplement and feed industries. The company markets its products under the name Altratene.

Allied Biotech Headlines

No Headlines